STOCK TITAN

[Form 4] Neogen Corp Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Neogen Corp (NEOG) insider activity: Amy M. Rocklin, Chief Legal Officer, had 10,324 restricted stock units vest on 08/18/2025 and those RSUs were settled into 10,324 shares at $5.43 per share. On the same date she acquired 10,324 shares and sold 3,005 shares at $5.43, leaving her with 44,170 shares beneficially owned following the transactions.

Operazioni interne di Neogen Corp (NEOG): Amy M. Rocklin, Chief Legal Officer, ha visto 10.324 unità di azioni vincolate (RSU) maturare il 08/18/2025; queste RSU sono state convertite in 10.324 azioni al prezzo di 5,43$ per azione. Nella stessa data ha acquisito 10.324 azioni e ne ha vendute 3.005 a 5,43$, portando il totale delle azioni di cui beneficia a 44.170 dopo le operazioni.

Actividad de insiders en Neogen Corp (NEOG): Amy M. Rocklin, Chief Legal Officer, tuvo 10.324 unidades de acciones restringidas (RSU) que vencieron el 08/18/2025; dichas RSU se convirtieron en 10.324 acciones a 5,43$ por acción. Ese mismo día adquirió 10.324 acciones y vendió 3.005 a 5,43$, quedando con 44.170 acciones en propiedad beneficiaria tras las transacciones.

Neogen Corp (NEOG) 내부자 거래: 최고법률책임자(Chief Legal Officer) Amy M. Rocklin은 2025-08-18(08/18/2025)에 10,324개의 제한주식단위(RSU)가 성립되었으며, 해당 RSU는 주당 5.43달러로 10,324주로 정산되었습니다. 같은 날 그녀는 10,324주를 취득하고 그중 3,005주를 주당 5.43달러에 매각하여, 거래 후 실질적으로 보유한 주식 수는 44,170주가 되었습니다.

Opérations d'initiés chez Neogen Corp (NEOG) : Amy M. Rocklin, Chief Legal Officer, a vu 10 324 unités d'actions restreintes (RSU) arriver à échéance le 08/18/2025 ; ces RSU ont été réglées par 10 324 actions au prix de 5,43$ par action. Le même jour, elle a acquis 10 324 actions et en a vendu 3 005 à 5,43$, ce qui lui laisse 44 170 actions en propriété bénéficiaire après les opérations.

Insider-Aktivitäten bei Neogen Corp (NEOG): Amy M. Rocklin, Chief Legal Officer, hatte am 08/18/2025 insgesamt 10.324 Restricted Stock Units (RSU), die fällig wurden; diese RSUs wurden zu je 5,43$ in 10.324 Aktien umgewandelt. Am gleichen Tag erwarb sie 10.324 Aktien und verkaufte 3.005 Aktien zu 5,43$, womit ihr nach den Transaktionen ein wirtschaftlicher Besitz von 44.170 Aktien verbleibt.

Positive
  • 10,324 RSUs vested and were settled into 10,324 shares, reflecting compensation execution as disclosed
  • Form 4 discloses transactions clearly with transaction dates, amounts, and prices, meeting Section 16 reporting requirements
Negative
  • 3,005 shares were disposed of on 08/18/2025 at $5.43, reducing the reporting person's holdings
  • Insufficient context on materiality relative to total company outstanding shares to assess impact on control or voting power

Insights

TL;DR: Routine executive equity vesting with a small concurrent sale, no material change to ownership stake.

The filing documents conversion of 10,324 RSUs into common shares at an indicated price of $5.43 and a concurrent disposition of 3,005 shares at the same price, leaving total beneficial ownership at 44,170 shares. This appears to be an expected compensation settlement rather than a signaling trade; the net change in holdings is modest relative to the reported post-transaction position.

TL;DR: Compensation-related vesting and settlement, properly reported under Section 16.

The report clarifies that RSUs vested and were settled for an equal number of shares on 08/18/2025 and the Form 4 was timely executed by an attorney-in-fact. The disclosure identifies the reporting person as the Chief Legal Officer and shows both acquisition (vesting settlement) and a partial sale, consistent with routine executive equity administration.

Operazioni interne di Neogen Corp (NEOG): Amy M. Rocklin, Chief Legal Officer, ha visto 10.324 unità di azioni vincolate (RSU) maturare il 08/18/2025; queste RSU sono state convertite in 10.324 azioni al prezzo di 5,43$ per azione. Nella stessa data ha acquisito 10.324 azioni e ne ha vendute 3.005 a 5,43$, portando il totale delle azioni di cui beneficia a 44.170 dopo le operazioni.

Actividad de insiders en Neogen Corp (NEOG): Amy M. Rocklin, Chief Legal Officer, tuvo 10.324 unidades de acciones restringidas (RSU) que vencieron el 08/18/2025; dichas RSU se convirtieron en 10.324 acciones a 5,43$ por acción. Ese mismo día adquirió 10.324 acciones y vendió 3.005 a 5,43$, quedando con 44.170 acciones en propiedad beneficiaria tras las transacciones.

Neogen Corp (NEOG) 내부자 거래: 최고법률책임자(Chief Legal Officer) Amy M. Rocklin은 2025-08-18(08/18/2025)에 10,324개의 제한주식단위(RSU)가 성립되었으며, 해당 RSU는 주당 5.43달러로 10,324주로 정산되었습니다. 같은 날 그녀는 10,324주를 취득하고 그중 3,005주를 주당 5.43달러에 매각하여, 거래 후 실질적으로 보유한 주식 수는 44,170주가 되었습니다.

Opérations d'initiés chez Neogen Corp (NEOG) : Amy M. Rocklin, Chief Legal Officer, a vu 10 324 unités d'actions restreintes (RSU) arriver à échéance le 08/18/2025 ; ces RSU ont été réglées par 10 324 actions au prix de 5,43$ par action. Le même jour, elle a acquis 10 324 actions et en a vendu 3 005 à 5,43$, ce qui lui laisse 44 170 actions en propriété bénéficiaire après les opérations.

Insider-Aktivitäten bei Neogen Corp (NEOG): Amy M. Rocklin, Chief Legal Officer, hatte am 08/18/2025 insgesamt 10.324 Restricted Stock Units (RSU), die fällig wurden; diese RSUs wurden zu je 5,43$ in 10.324 Aktien umgewandelt. Am gleichen Tag erwarb sie 10.324 Aktien und verkaufte 3.005 Aktien zu 5,43$, womit ihr nach den Transaktionen ein wirtschaftlicher Besitz von 44.170 Aktien verbleibt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rocklin Amy M

(Last) (First) (Middle)
620 LESHER PLACE

(Street)
LANSING MI 48912

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NEOGEN CORP [ NEOG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Legal Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/18/2025 M 10,324 A $5.43 47,175 D
Common Stock 08/18/2025 F 3,005 D $5.43 44,170 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $5.43 08/18/2025 M 10,324 08/18/2025 08/18/2025 Common Stock 10,324 $5.43 20,648 D
Explanation of Responses:
Remarks:
Each RSU is the economic equivalent of one share of common stock. On August 18, 2025, these RSUs vested and were settled for an equal number of shares of common stock.
Christopher Sefcheck (Attorney in Fact) 08/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What happened in the NEOG Form 4 filed for Amy M. Rocklin?

The filing shows 10,324 RSUs vested and were settled into 10,324 shares on 08/18/2025 and 3,005 shares were sold at $5.43, leaving 44,170 shares beneficially owned.

How many shares did Amy M. Rocklin own after the transactions?

Following the reported transactions on 08/18/2025, the filing reports 44,170 shares beneficially owned.

What was the price per share for the transactions reported on Form 4?

The transactions are reported at a price of $5.43 per share.

Were the vested RSUs converted into shares according to the filing?

Yes. The filing states that each RSU vested and was settled for an equal number of shares of common stock on 08/18/2025.

Who signed the Form 4 and when was it dated?

The Form 4 was signed by Christopher Sefcheck (Attorney in Fact) and dated 08/20/2025.
Neogen Corp

NASDAQ:NEOG

NEOG Rankings

NEOG Latest News

NEOG Latest SEC Filings

NEOG Stock Data

1.21B
215.75M
0.38%
112.82%
7.94%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States
LANSING